Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 424,426 | 80,951 | 357,399 | 734,577 | 185,925 |
| Cost of Goods | 55,777 | 34,086 | 181,765 | 434,593 | 271,077 |
| Gross Profit | 368,649 | 46,865 | 175,634 | 299,984 | -85,152 |
| Operating Expenses | 313,969 | 359,719 | 420,278 | 427,766 | 397,885 |
| Operating Income | 55,457 | -312,768 | -243,879 | -127,189 | -482,960 |
| Interest Expense | 3,124 | 4,316 | 4,601 | 4,169 | 6,234 |
| Other Income | 5,532 | 24,362 | 63,971 | -34,783 | -19,873 |
| Pre-tax Income | 57,865 | -292,722 | -184,509 | -166,141 | -509,067 |
| Income Tax | -143 | 1,183 | -2,260 | 2,472 | 1,418 |
| Net Income Continuous | 58,008 | -293,905 | -182,249 | -168,613 | -510,485 |
| Net Income | $58,008 | $-293,905 | $-182,249 | $-168,613 | $-510,485 |
| EPS Basic Total Ops | 0.65 | -3.41 | -2.40 | -2.15 | -6.53 |
| EPS Basic Continuous Ops | 0.65 | -3.41 | -2.39 | -2.15 | -6.53 |
| EPS Diluted Total Ops | 0.58 | -3.41 | -2.30 | -2.15 | -6.53 |
| EPS Diluted Continuous Ops | 0.56 | -3.41 | -2.25 | -2.15 | -6.53 |
| EBITDA(a) | $65,524 | $-303,725 | $-236,657 | $-118,842 | $-476,240 |